Drug Regulation & QMS – Late May 2021

Regulatory requirements and quality issues are important already in the beginning of drug related research and during the R&D stage. The workshop deals with early-stage drug development aspects by Fimea and a drug development company  and ends with 1-on-1 meetings.  The speakers are not confirmed.